OraSure Technologies Inc gross margin has been in long-term decline. The average rate of decline per year is -8.4%.
The historical rank and industry rank for OraSure Technologies's Gross Margin % or its related term are showing as below:
OSUR'
s Gross Margin % Range Over the Past 10 Years
Min: 38.31 Med: 59.28 Max: 68.66
Current: 42.72
During the past 13 years, the highestGross Margin % of OraSure Technologies was 68.66%. The lowest was 38.31%. And the median was 59.28%.
OSUR's Gross Margin % is ranked worse than 66.17% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 53.03
vs OSUR: 42.72
OraSure Technologies had a gross margin of 36.23% for the quarter that ended in Dec. 2024 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for OraSure Technologies was -8.40% per year.
OraSure Technologies Gross Margin % Historical Data
The historical data trend for OraSure Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OraSure Technologies's Gross Margin %
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
OraSure Technologies had a gross margin of 36.23% for the quarter that ended in Dec. 2024 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
OraSure Technologies Gross Margin % Related Terms
Thank you for viewing the detailed overview of OraSure Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSUR has been successfully added to your 